Results 31 to 40 of about 247,613 (164)
, 2010 肝性脑病是各种严重肝脏疾病所致的中枢神经系统功能失调综合征。目前运用脑功能成像技术尤其是PET、fMRI来研究肝性脑病脑功能代谢及认知功能的改变已经成为一大热点 ...
廖玲敏 +3 more
core +1 more source
, 2017 为促进我国肝纤维化、肝硬化诊断治疗和科研水平的提高,由中华医学会肝病学分会主办、肝纤维化学组和湖南省医学会承办,于2016年9月9日至11日在湖南省长沙市召开了第五次全国肝纤维化、肝硬化学术会议.从事肝病临床和基础研究工作的医务人员及科研人员500余人参加了会议,与会专家就国内外肝纤维化、肝硬化研究进展及热点问题进行了学术报告与研讨.161 ...
马红, 徐小元
core +1 more source
无创肝纤维化评分与非酒精性脂肪性肝病患者并发慢性肾病风险的关系研究
Zhongguo shiyan zhenduanxue, 2020 非酒精性脂肪性肝病(NAFLD)是全球范围内最常见的慢性肝病之一[1,2]。研究表明,非酒精性脂肪性肝病不仅可导致肝脏损伤,还可增加肝外疾病如冠状动脉疾病、肾脏疾病的发生风险[3-5]。其中,非酒精性脂肪性肝病与慢性肾脏疾病风险的关系,最为引人关注[6-9]。本研究评估非酒精性脂肪性肝病人群的慢性肾病的发生风险,以及其与无创肝纤维化评分的关系。
吴迪, 宋玲玲
doaj
Animal Models and Experimental Medicine, Volume 8, Issue 8, Page 1387-1399, August 2025.Post‐stroke depression (PSD) animal model of traditional Chinese medicine (TCM) combined with disease and syndrome often uses western medicine surgery (including: middle cerebral artery embolization to construct cerebral ischemia, or brain injection of collagenase to construct cerebral hemorrhage) combined with other methods (including: isolation ...
Jielin Wang +4 more
wiley +1 more source
The First CSH-AASLD Dialogue: meeting highlights and minutes
, 2016 由中华医学会肝病学分会主办的“中华医学会肝病学分会和美国肝病研究学会首次联合会议”分别于2015年7月18日在北京、2015年7月19日在上海召开.美国肝病研究学会(American Association for the Study of Liver Disease,AASLD)候任主席(2017年)、美国密歇根大学骆淑芳(Anna Suk-Fong Lok)教授、中华医学会肝病学分会(Chinese Society of Hepatology,CSH)主任委员魏来教授 ...
魏来 +4 more
core +1 more source
Combating infections under siege: Healthcare challenges amidst the military assault in Gaza
World Medical &Health Policy, Volume 17, Issue 1, Page 188-213, March 2025.Abstract The ongoing Israeli military assault on Gaza has caused a devastating collapse of healthcare infrastructure, resulting in an unprecedented surge in infectious diseases. The destruction of sanitation systems, restrictions on medical supplies, and displacement of civilians have created an environment conducive to the rapid spread of waterborne ...
Bilal Irfan +24 more
wiley +1 more source
Role of pegylated-interferon in the treatment of hepatitis C in Chinese patients
, 2015 丙型肝炎已成为全球性的公共卫生问题.世界卫生组织(WHO)报告全世界超过1.85亿人感染丙型肝炎病毒(HCV),每年35万例的患者因HCV相关肝硬化和肝癌死亡[1].慢性丙型肝炎的主要治疗目标是实现持续病毒学应答(SVR),治愈疾病,从而防止疾病进展,同时预防疾病传播.直至2011年直接抗病毒药物(DAAs)应用于临床实践之前,聚乙二醇干扰素(PEG-IFN)联合利巴韦林(RBV)仍是全球慢性丙型肝炎治疗的标准方案.中文核心期刊要目总览(PKU)中国科技核心期刊(ISTIC)中国科学引文数据库(CSCD)
窦晓光 +5 more
core +1 more source
Evidence-Based Complementary and Alternative Medicine, Volume 2019, Issue 1, 2019., 2019 A survey study was conducted in Korean medicine doctors who provide nonsurgical integrative treatment for cervical disc herniation (CDH) at spine‐specialty hospitals to assess usual treatment practices, diagnosis and treatment methods, and related adverse events for CDH.
Hee Seung Choi +7 more
wiley +1 more source
To improve the accessibility of hepatitis B treatment
, 2016 我国慢性乙型肝炎负担严重,估计慢性乙型肝炎为9 000万例,其中700万例为慢性乙型肝炎引起的进展期肝病和肝癌高危患者,他们急需治疗.但目前仅约10％慢性乙型肝炎患者接受抗病毒治疗.为了提高慢性乙型肝炎患者抗病毒治疗的可及性,应降低抗病毒药物的价格、将抗病毒药物纳入国家基本药物目录,以及住院和门诊慢性乙型肝炎患者的医保报销,并采取药物降价机制如驳回某些影响公共卫生和医保政策的国外药品专利注册、启动政府与药厂谈判统一的药品价格等.The burden of chronic hepatitis B is ...
庄辉
core +1 more source